Safety and efficacy of cutting balloon angioplasty: The Mayo Clinic experience

James L. Orford, Panayotis Fasseas, Ali E. Denktas, La Von Hammes, Kirk N. Garratt, Peter B. Berger, David R. Holmes, Gregory W. Barsness

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


A number of evolving clinical indications for cutting balloon angioplasty (CBA) have been described in the clinical literature, including angioplastyresistant stenoses, in-stent restenosis, ostial lesions and small vessel disease. Methods. We analyzed the Mayo Clinic PTCA registry and report procedural and in-hospital clinical outcomes in 100 patients (103 procedures, 114 lesions) undergoing CBA. Results. CBA was successfully completed in 109 lesions (96%). The majority of lesions (73%) required additional treatment with either balloon angioplasty (39%) or stent implantation (34%). Severe intimal dissection resulting in at least 50% luminal obstruction occurred in 13 lesions (11%). A single incident of branch occlusion was documented, resulting in ST elevation myocardial infarction. There were no incidents of vessel perforation, urgent percutaneous or surgical target vessel revascularization, or in-hospital death. Conclusion. CBA is feasible and safe, with a low incidence of procedural complications and in-hospital adverse cardiac events when used primarily for in-stent restenosis.

Original languageEnglish (US)
Pages (from-to)720-724
Number of pages5
JournalJournal of Invasive Cardiology
Issue number12
StatePublished - Dec 2002


  • Dissection
  • Perforation
  • Restenosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Safety and efficacy of cutting balloon angioplasty: The Mayo Clinic experience'. Together they form a unique fingerprint.

Cite this